2024 Neuroimaging Reading List

Reading List

Please click below to access the 2024 Neuroimaging reading list.

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

• Explain how functional neuroimaging and neuroimaging patterns can identify and potentially treat patients with neurodegenerative disorders
• Identify overlapping neuroimaging patterns between demyelinating disorders and anoxic brain injury disorders to properly diagnose various disease states
• Evaluate the different manifestations of traumatic brain injury via neuroimaging and functional neuroimaging
• Review functional neuroimaging as a potential aid in predicting outcomes in critically ill patients

Core Competencies

• Medical Knowledge
• Patient Care
• Practice-Based Learning and Improvement

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within 24 hours of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 15 AMA PRA Category 1^TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry and Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved this activity as part of a comprehensive self-assessment (SA) CME activity, which is mandated by the American Board of Medical Specialties (ABMS) as a necessary component of continuing certification.

Disclosures

The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy. 

2024 C-cert Activity Planner (Certification Council) Disclosures
All relevant financial relationships have been mitigated.

Neuroimaging Certification Examination Committee Contributors

Jennifer Williams McVige, MD, Chair, Dent Neurologic Institute
Disclosures: Received personal compensation from Impel, AbbVie, Avanir, and Biohaven for consulting work; received personal compensation for serving on speaker’s bureau for AbbVie, Avanir, Impel, Biohaven, and Teva; received research support from Allergan, AEON, Amgen, Biohaven, Avanir - research trials; serve on Board of Directors - American Society of Neuroimaging; work on editing the imaging test questions for the ABPN but don’t write questions for them.

Gregory Kapinos, MD, MS, HEC-C, Vice Chair, NYC Health + Hospitals/Elmhurst
Disclosures: Nothing to disclose.

Madhureeta Achari, MD, Integrated Neurology, PA
Disclosures: Received personal compensation for serving as a consultant for Lilly; served on two Advisory Boards; received personal compensation for serving as an expert witness for multiple law firms with 50-50 work on plaintiff and defense sides.

Carmel Armon, MD, MHS, Shamir (Assaf Harofeh) Medical Center, Israel 
Disclosures: Received personal compensation for serving as Associate Editor, Journal of Neurological Sciences; received personal compensation for serving as an expert witness: 1. Expert witness for the court in three cases in Israel; 2. Expert witness for various plaintiffs or defendants - private individuals; 3. Consultant in neurology to Inbal - The internal insurance company for the State of Israel (payment is for specific time spent providing opinions, not a global consulting fee).

John A. Bertelson, MD, Texas Tech School of Medicine
Disclosures: Received compensation from Ascension Seton, employed neurologist; Texas Tech School of Medicine, employed neurologist; Senior Adults Specialty Healthcare, employed neurologist; Received compensation for serving on advisory board, TARCC (Texas Alzheimer's research and care consortium) representing Texas Tech and Eisai and for serving on speaker’s bureau for Leqembi (just finished training, have not spoken yet); received compensation as expert witness neurologist, generally retained by the defense of concussion-related litigation (multiple insurance carriers); Apple stockholder, <$500,000.

Dimitrios Giannakidis, MD, Sutter West Bay Medical Group
Disclosures: Nothing to disclose.

Mohammad Obadah Nakawah, MD, Houston Methodist Neurological Institute 
Disclosures: Nothing to disclose.

Gustavo J. Rodriguez, MD, Texas Tech Physicians of El Paso
Disclosures: Nothing to disclose.

Catherine A. Weymann-McKinney, MD, Lake Norman Neurology Hickory – Piedmont Healthcare
Disclosures: Nothing to disclose.

Oana Dumitrascu, MD, MS, Mayo Clinic - Scottsdale
Disclosures: Nothing to disclose.

Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326